Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
NYMXFNymox Pharmaceutical Corp
| Figure | NYMXFNymox Pharmaceutical CorpFY2023 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $4.49M |
| Net income, yoy | +49.2% |
| Net margin | — |
| Free cash flow | $2.60M |
| FCF margin | — |
| EPS, diluted | — |
Add another company.
Annual · FY2019–FY2023 · USD
From SEC EDGARSame fiscal periods, as filed